QSA's Week in BioPharma (#7, 2025)
Canada invests in Eastern Ontario life sciences; Avian flu vaccine acquisition; HPV test expands in Quebec; BC addresses opioid crisis.
Start Date: 2025-02-15
End Date: 2025-02-21
Top Headlines
Main Stories
Canada Invests $3.4 Million in Eastern Ontario Life Sciences Sector
The Government of Canada announced significant investments in Eastern Ontario's life sciences sector, focusing on Kingston and Prescott-Russell. Minister Ruby Sahota revealed a $3.4 million investment for the Kingston Economic Development Corporation to enhance life sciences infrastructure, including new wet lab spaces. This initiative aims to bolster innovation and commercialization efforts, supporting over 100 businesses. Additionally, nearly $400,000 will be allocated to boost services for SMEs in Prescott-Russell, particularly in attracting bilingual workers.
Sources: Announcements: www.canada.ca, Announcements: www.canada.ca
Canada Secures Avian Influenza Vaccine Supply
The Public Health Agency of Canada has procured 500,000 doses of the ArepanrixTM H5N1 vaccine from GSK to protect individuals at risk of avian influenza exposure. This proactive measure forms part of Canada's contingency strategy to manage potential health threats. The distribution strategy involves 60% of doses going to provinces and territories, while 40% remain in federal reserves for national preparedness.
Sources: Announcements: www.canada.ca
